Our Model
Built for Scalability, Not One-Off Success
Buffalo operates as a portfolio platform, not a single-asset fund.
Pipeline
We source programs through trusted rare disease networks, focusing on:
- Ultra-rare Diseases
- Validated Disease Biology
- Clear Therapeutic Strategy
- Patient Organizations Ready to Lead
Accelerator
We provide the expertise patient leaders need most:
- Regulatory & FDA engagement strategy
- Guidance on IND-enabling studies
- Clinical trial design
- Access to manufacturing partnerships
- Shared operational infrastructure
Open-Source Infrastructure
Every program strengthens the whole system:
- Trial design templates
- Regulatory playbooks
- Manufacturing protocols
- Endpoint validation data
No reinvention. Faster timelines. Lower costs.
Blended Capital
Financing Aligned with Biology
Buffalo combines philanthropic early-risk capital with mission-aligned investment capital
Returns are generated through:
- Equity
- Royalties
- Structured milestone payouts
- Reinvestment into new programs